• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Marillyn Hewson Joins Chevron’s Board of Directors

    12/2/20 4:30:00 PM ET
    $JNJ
    $CVX
    $LMT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Integrated oil Companies
    Energy
    Get the next $JNJ alert in real time by email

    SAN RAMON, Calif.--(BUSINESS WIRE)--Chevron Corporation (NYSE: CVX) announced that Marillyn A. Hewson has been elected to Chevron’s board of directors, effective on January 1, 2021. She will serve on the Audit Committee of the Board.

    Hewson, 66, is executive chairman of Lockheed Martin Corporation. She served as Lockheed Martin’s chairman, president and chief executive officer from January 2014 to June 2020 and held the positions of president and chief executive officer from January 2013 to December 2013.

    “It’s truly an honor to welcome Marillyn to Chevron’s board,” said Chevron Chairman and CEO Michael Wirth. “Marillyn is one of the world’s most accomplished business leaders. She brings valuable global business experience as well as decades of perspective on international commerce and geopolitics to our board, and will make our company better.”

    Hewson joined Lockheed Martin more than 35 years ago as an industrial engineer. During her career she has held leadership positions across the corporation. She currently serves on the board of directors of Johnson & Johnson, the Congressional Medal of Honor Foundation, the Board of Governors of the USO, and as chair of the Catalyst Board of Directors. Hewson has served on several U.S. government advisory bodies, including her current appointment to the American Workforce Policy Advisory Board. She earned her Bachelor of Science degree in business administration and her Master of Arts degree in economics from The University of Alabama and has completed executive development programs at Columbia Business School and Harvard Business School.

    Chevron Corporation is one of the world’s leading integrated energy companies. Through its subsidiaries that conduct business worldwide, the company is involved in virtually every facet of the energy industry. Chevron explores for, produces and transports crude oil and natural gas; refines, markets and distributes transportation fuels and lubricants; manufactures and sells petrochemicals and additives; generates power; and develops and deploys technologies that enhance business value in every aspect of the company’s operations. Chevron is based in San Ramon, Calif. More information about Chevron is available at www.chevron.com.

    Get the next $JNJ alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $JNJ
    $CVX
    $LMT

    CompanyDatePrice TargetRatingAnalyst
    Johnson & Johnson
    $JNJ
    5/13/2025$153.00Outperform → Market Perform
    Leerink Partners
    Chevron Corporation
    $CVX
    5/13/2025$158.00Buy → Hold
    HSBC Securities
    Chevron Corporation
    $CVX
    5/6/2025$130.00Buy → Sell
    DZ Bank
    Chevron Corporation
    $CVX
    5/5/2025$155.00 → $150.00Hold
    TD Cowen
    Chevron Corporation
    $CVX
    4/23/2025$124.00Neutral → Sell
    Redburn Atlantic
    Lockheed Martin Corporation
    $LMT
    4/23/2025$540.00Neutral → Outperform
    Robert W. Baird
    Chevron Corporation
    $CVX
    4/23/2025$171.00 → $152.00Overweight → Equal Weight
    Barclays
    Lockheed Martin Corporation
    $LMT
    4/16/2025$575.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $JNJ
    $CVX
    $LMT
    SEC Filings

    See more
    • Johnson & Johnson filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - JOHNSON & JOHNSON (0000200406) (Filer)

      6/10/25 5:06:51 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chevron Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - CHEVRON CORP (0000093410) (Filer)

      5/30/25 4:16:40 PM ET
      $CVX
      Integrated oil Companies
      Energy
    • SEC Form SD filed by Lockheed Martin Corporation

      SD - LOCKHEED MARTIN CORP (0000936468) (Filer)

      5/28/25 4:37:28 PM ET
      $LMT
      Military/Government/Technical
      Industrials

    $JNJ
    $CVX
    $LMT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Hewson Marillyn A

      4 - JOHNSON & JOHNSON (0000200406) (Issuer)

      6/12/25 4:32:25 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Woods Eugene A.

      4 - JOHNSON & JOHNSON (0000200406) (Issuer)

      6/12/25 4:30:37 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • New insider Booth Thomas Ryder claimed ownership of 3,181 shares (SEC Form 3)

      3 - CHEVRON CORP (0000093410) (Issuer)

      6/9/25 4:54:11 PM ET
      $CVX
      Integrated oil Companies
      Energy

    $JNJ
    $CVX
    $LMT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Weinberger Mark A bought $147,220 worth of shares (1,000 units at $147.22) (SEC Form 4)

      4 - JOHNSON & JOHNSON (0000200406) (Issuer)

      12/12/24 5:27:36 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $JNJ
    $CVX
    $LMT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Lockheed Martin and Electra Expand Collaboration to Accelerate EL9 Ultra-STOL Commercialization

      PARIS, June 19, 2025 /PRNewswire/ -- Lockheed Martin Skunk Works® (NYSE:LMT) and Electra.aero, Inc. ("Electra") signed a Memorandum of Understanding to explore opportunities for Electra's EL9 ultra-short takeoff and landing (Ultra-STOL) aircraft. Electra's EL9 will transform military aviation for last mile logistics, mobile power generation and emergency response.Lockheed Martin, a global defense technology company, will collaborate with Electra to explore ways to accelerate the development of the EL9 in areas including digital engineering, manufacturing, supply chain, sustain

      6/19/25 3:00:00 AM ET
      $LMT
      Military/Government/Technical
      Industrials
    • Johnson & Johnson Hit With $8M Verdict in Massachusetts Mesothelioma Talc Lawsuit

      Jury concludes J&J concealed the danger of its asbestos-laced talcum powder that caused woman's cancer A Suffolk County jury has awarded $8 million in favor of Janice Paluzzi, a Massachusetts woman who developed mesothelioma after decades of using Johnson & Johnson's (NYSE:JNJ) talcum powder products. The jury found the pharmaceutical giant liable for negligence and breach of warranty, concluding that the company's asbestos-contaminated talcum powder products caused Paluzzi's terminal cancer. During the trial, the Dean Omar Branham Shirley legal team, which represented Ms. Paluzzi, presented extensive evidence showing that Johnson & Johnson had internal knowledge of asbestos in its ta

      6/18/25 6:43:00 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Lockheed Martin Unveils Groundbreaking C-130J Super Hercules Performance Results

      PARIS, June 18, 2025 /PRNewswire/ -- Lockheed Martin (NYSE:LMT) continues to revolutionize the future of tactical airlift with the C-130J Super Hercules and today announced a major breakthrough in wing structure testing that greatly exceeded expectations, by validating the extended wing life of the C-130J and structural superiority of the center wing box. After a rigorous testing program, the C-130J's wing structure has proven to offer nearly 40% more lifespan compared to initial estimates and nearly twice the specification design life. The test result demonstrated a significa

      6/18/25 7:59:00 AM ET
      $LMT
      Military/Government/Technical
      Industrials

    $JNJ
    $CVX
    $LMT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Johnson & Johnson downgraded by Leerink Partners with a new price target

      Leerink Partners downgraded Johnson & Johnson from Outperform to Market Perform and set a new price target of $153.00

      5/13/25 8:56:13 AM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chevron downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded Chevron from Buy to Hold and set a new price target of $158.00

      5/13/25 8:52:41 AM ET
      $CVX
      Integrated oil Companies
      Energy
    • Chevron downgraded by DZ Bank with a new price target

      DZ Bank downgraded Chevron from Buy to Sell and set a new price target of $130.00

      5/6/25 8:02:15 AM ET
      $CVX
      Integrated oil Companies
      Energy

    $JNJ
    $CVX
    $LMT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • July 21, 2023 - FDA Roundup: July 21, 2023

      For Immediate Release: July 21, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA Center for Tobacco Products (CTP) announced that the center will host a virtual listening session on Aug. 22, 2023. During this listening session, CTP is requesting feedback on the development of a new 5-year strategic plan for the center, includin

      7/21/23 4:02:23 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • May 5, 2022 - Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals

      For Immediate Release: May 05, 2022 Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not

      5/5/22 4:51:11 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • August 18, 2021 - Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots

      For Immediate Release: August 18, 2021 Today, public health and medical experts from the U.S. Department of Health and Human Services (HHS) released the following statement on the Administration’s plan for COVID-19 booster shots for the American people. The statement is attributable to Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention (CDC); Dr. Janet Woodcock, Acting Commissione

      8/18/21 1:06:11 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $JNJ
    $CVX
    $LMT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Johnson & Johnson

      SC 13G - JOHNSON & JOHNSON (0000200406) (Filed by)

      4/10/24 5:12:55 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G/A filed by Johnson & Johnson (Amendment)

      SC 13G/A - JOHNSON & JOHNSON (0000200406) (Subject)

      2/13/24 5:07:58 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G/A filed by Chevron Corporation (Amendment)

      SC 13G/A - CHEVRON CORP (0000093410) (Subject)

      2/13/24 4:55:53 PM ET
      $CVX
      Integrated oil Companies
      Energy

    $JNJ
    $CVX
    $LMT
    Leadership Updates

    Live Leadership Updates

    See more
    • Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors

      Johnson & Johnson (NYSE:JNJ) announced today that Daniel Pinto, President, JPMorganChase, has been elected to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610707025/en/ "We are thrilled to have Daniel join Johnson & Johnson's Board of Directors," said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. "He is an exceptional leader with deep financial expertise and understanding of global capital markets. Daniel's unique perspective and wealth of experience will be a tremendous asset to Johnson & Johnson as we continue to invest in and advance the next generation of healthcare inno

      6/10/25 4:51:00 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chevron Updates Stockholders at Annual Meeting

      Chevron Corporation (NYSE:CVX) today provided an overview of the company's business performance and plans at its Annual Meeting of Stockholders. The meeting highlighted the company's strong performance and consistent strategy, with stockholders showing their support by voting in favor of the full slate of Directors and with the company's recommendations on all matters to be voted upon. "Our strong performance in 2024 and through the first quarter reflects strong project execution and cost and capital discipline," said Mike Wirth, Chevron's chairman and chief executive officer. "We appreciate the confidence our stockholders have shown in our governance and performance and look forward to c

      5/28/25 4:00:00 PM ET
      $CVX
      Integrated oil Companies
      Energy
    • ISS and Glass Lewis Join ADL and JLens in Recommending AGAINST Anti-Israel Shareholder Proposals at Intel, General Dynamics and Lockheed Martin

      Reiterates Call for Shareholders to Reject Proposals Motivated by Antisemitic Boycott, Divestment and Sanctions (BDS) Movement ADL (Anti-Defamation League) and its affiliate, Jlens, welcome the decisions of the two leading independent proxy advisory firms, Institutional Shareholder Services ("ISS") and Glass, Lewis & Co. ("Glass Lewis"), to recommend that investors vote AGAINST anti-Israel shareholder proposals at the upcoming annual meetings of Intel Corporation (NASDAQ:INTC), General Dynamics (NYSE:GD) and Lockheed Martin Corporation (NYSE:LMT). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505942003/en/ ADL and its Regist

      5/5/25 8:00:00 AM ET
      $GD
      $INTC
      $LMT
      Marine Transportation
      Industrials
      Semiconductors
      Technology

    $JNJ
    $CVX
    $LMT
    Financials

    Live finance-specific insights

    See more
    • Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

      Johnson & Johnson (NYSE:JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Wednesday, July 16th to review second-quarter results. Joaquin Duato, Chairman and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Darren Snellgrove, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson's executive team. Investors and other interested parties can access the webcast/conference call in the following ways: The webcast and presentation material are accessible at Johnson & Johnson's website www.investor.jnj.com. A replay o

      5/28/25 4:43:00 PM ET
      $JNJ
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Lockheed Martin Declares Second Quarter 2025 Dividend

      BETHESDA, Md., May 9, 2025 /PRNewswire/ -- The Lockheed Martin Corporation (NYSE:LMT) board of directors has authorized a second quarter 2025 dividend of $3.30 per share. The dividend is payable on June 27, 2025, to holders of record as of the close of business on June 2, 2025. About Lockheed MartinLockheed Martin is a global defense technology company driving innovation and advancing scientific discovery. Our all-domain mission solutions and 21st Century Security® vision accelerate the delivery of transformative technologies to ensure those we serve always stay ahead of ready

      5/9/25 4:30:00 PM ET
      $LMT
      Military/Government/Technical
      Industrials
    • Chevron Reports First Quarter 2025 Results

      Reported earnings of $3.5 billion; adjusted earnings of $3.8 billion Returned $6.9 billion cash to shareholders; acquired $2.2 billion of Hess shares Started production from Ballymore field in the Gulf of America in April Chevron Corporation (NYSE:CVX) reported earnings of $3.5 billion ($2.00 per share - diluted) for first quarter 2025, compared with $5.5 billion ($2.97 per share - diluted) in first quarter 2024. Included in the quarter was a net loss of $175 million related to legal reserves and a tax charge due to changes in the energy profits levy in the United Kingdom that were partially offset by the fair value measurement of Hess Corporation shares. Foreign currency effects dec

      5/2/25 6:15:00 AM ET
      $CVX
      Integrated oil Companies
      Energy